The activation of THR is known to improve MASH by controlling fat synthesis, regulating fatty acid oxidation, cholesterol metabolism, mitochondrial function, and reducing inflammation and fibrosis
Simultaneously, possible variance difference between the samples was assessed by F-test which showed no difference between groups thus validating the adequacy of the t test analysis
More potent than its predecessors, retatrutide activates three receptorsGLP-1, GIP, and glucagonas opposed to only one (as is the case with semaglutide) or two (like tirzepatide)
As with any therapy, its essential to assess traditional risk factorssuch as gallstones, severe hypertriglyceridemia, and alcohol useand to monitor patients appropriately.
This avoids stomach irritation and ensures steady absorption